Rhythm Pharmaceuticals股票：看好理由仍在，但市场已计入大量乐观预期（RYTM）
· seekingalpha.com
鉴于IMCIVREE销售额同比增长79.5%，Rhythm Pharmaceuticals值得买入，但27.4倍的追踪销售额和不断上升的成本增加了执行风险。在此了解更多RYTM股票信息。
Rhythm Pharmaceuticals Inc. ( RYTM ) stock has seen quite a bit of momentum since I last covered it. Shares are up about 30% on the 6-month chart here. But afte...